Your browser doesn't support javascript.
loading
Clinical Observation of Bevacizumab Combined with S-1 in the Treatment of Pretreated Advanced Esophageal Carcinoma.
Nie, Keke; Geng, Chuanxin; Zhang, Ling; Liu, Shichao; Zhang, Zhongfa; Wang, Rong; Zou, Xiao; Ji, Youxin.
Afiliação
  • Nie K; Department of Oncology, Qingdao Cancer Hospital, Qingdao, Shandong 266042, China.
  • Geng C; Department of Oncology, Qingdao Cancer Hospital, Qingdao, Shandong 266042, China.
  • Zhang L; Department of Oncology, Qingdao Cancer Hospital, Qingdao, Shandong 266042, China.
  • Liu S; Department of Oncology, Qingdao Cancer Hospital, Qingdao, Shandong 266042, China.
  • Zhang Z; Department of Oncology, Qingdao Cancer Hospital, Qingdao, Shandong 266042, China.
  • Wang R; Department of Oncology, Qingdao Central Hospital, 2nd Affiliated Hospital of Qingdao University, Qingdao,Shandong 266042, China.
  • Zou X; Department of Oncology, Qingdao Central Hospital, 2nd Affiliated Hospital of Qingdao University, Qingdao,Shandong 266042, China.
  • Ji Y; Department of Oncology, Qingdao Central Hospital, 2nd Affiliated Hospital of Qingdao University, Qingdao,Shandong 266042, China.
Chin Med Sci J ; 31(4): 221-7, 2016 11 20.
Article em En | MEDLINE | ID: mdl-28065218
Buscar no Google
Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Ácido Oxônico / Neoplasias Esofágicas / Protocolos de Quimioterapia Combinada Antineoplásica / Tegafur / Bevacizumab Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Chin Med Sci J Assunto da revista: TERAPIAS COMPLEMENTARES Ano de publicação: 2016 Tipo de documento: Article País de afiliação: China
Buscar no Google
Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Ácido Oxônico / Neoplasias Esofágicas / Protocolos de Quimioterapia Combinada Antineoplásica / Tegafur / Bevacizumab Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Chin Med Sci J Assunto da revista: TERAPIAS COMPLEMENTARES Ano de publicação: 2016 Tipo de documento: Article País de afiliação: China